Anzeige
Mehr »
Login
Samstag, 17.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Breaking News! Taat Lifestyle meldet riesige Kauforder!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU89 ISIN: US02083G1004 Ticker-Symbol: 34LA 
Frankfurt
16.04.21
15:45 Uhr
9,300 Euro
+0,700
+8,14 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ALPINE IMMUNE SCIENCES INC Chart 1 Jahr
5-Tage-Chart
ALPINE IMMUNE SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
9,1009,30016.04.
9,0009,40016.04.

Aktuelle News zur ALPINE IMMUNE SCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoAlpine Immune Sciences Is A Blind Buy After The Recent Price Decrease1
19.03.Why Alpine Immune Sciences Is Trading Lower Today4
19.03.Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q4 2020 Results - Earnings Call Transcript3
ALPINE IMMUNE SCIENCES Aktie jetzt für 0€ handeln
18.03.SRPT, UPST, MRKR and ALPN among after-hours movers9
18.03.ALPINE IMMUNE SCIENCES, INC. - S-8, Securities to be offered to employees in employee benefit plans1
18.03.Alpine Immune Sciences EPS beats by $0.04, beats on revenue1
18.03.ALPINE IMMUNE SCIENCES, INC. - 10-K, Annual Report-
18.03.ALPINE IMMUNE SCIENCES, INC. - 8-K, Current Report-
11.12.20ALPINE IMMUNE SCIENCES, INC. - 8-K, Current Report30
04.12.20Alpine Immune Sciences (ALPN) Investor Presentation - Slideshow15
13.11.20Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2020 Results - Earnings Call Transcript13
22.10.20AlPN vapor phase epitaxy on GaN9
19.06.20FDA Nod For EPZM, Ultragenyx, Court Rules In Mylan's Favor, Ocuphire To Hop Onto Nasdaq, Alpine Immune Soars529CANONSBURG (dpa-AFX) - Today's Daily Dose brings you news about Alpine Immune's deal with AbbVie; FDA approval of Epizyme's TAZVERIK and Ultragenyx Pharma's Crysvita for new indications; ...
► Artikel lesen
18.06.20Stock Alert: Alpine Immune Jumps 100% After Inking Deal With AbbVie434WASHINGTON (dpa-AFX) - Shares of Alpine Immune Sciences, Inc. (ALPN) more-than-doubled on Thursday morning. The company signed a deal with AbbVie Inc. (ABBV) for the development and commercialization...
► Artikel lesen
18.06.20Alpine Immune, AbbVie Enter Into Option And License Deal For ALPN-101426WASHINGTON (dpa-AFX) - Alpine Immune Sciences, Inc. (ALPN), a clinical-stage immunotherapy company, and biopharmaceutical company AbbVie Inc. (ABBV), said Thursday they have entered into an...
► Artikel lesen
04.06.20Alpine Immune Sciences Presents Preclinical Data on Novel Dual BAFF/APRIL Inhibitory Domains for B cell Mediated Autoimmune Diseases at the European Congress of Rheumatology E-Congress 2020293First presentation of Alpine's Variant Tumor Necrosis Factor (TNF) Receptor Domain (vTD) Program demonstrating expanded applicability of its directed evolution platform Alpine Immune Sciences,...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3